Actively Recruiting

Phase Not Applicable
Age: 60Years +
MALE
NCT07344844

Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer

Led by Clinique Sainte Clotilde · Updated on 2026-01-15

100

Participants Needed

1

Research Sites

180 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study evaluates whether adaptive stereotactic body radiotherapy (SBRT) provides dosimetric advantages compared to non-adaptive SBRT in localized prostate cancer. Five low-dose CT scans are performed before each SBRT session to assess anatomical variations (bladder filling, rectal volume) and determine if a dosimetric recalculation would have been required. The study also evaluates cumulative dose to organs at risk, patient-reported quality of life over 24 months, and overall and recurrence-free survival.

CONDITIONS

Official Title

Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer

Who Can Participate

Age: 60Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male aged 60 years or older
  • Diagnosed with localized prostate cancer of low or intermediate risk (T1-T2)
  • Gleason score between 6 and 7
  • PSA level less than 15 ng/mL
  • No evidence of metastatic disease
  • Radiotherapy is indicated for prostate cancer treatment
  • Affiliated with or benefiting from the French social security system
  • Patient speaks French
  • Patient has been informed and has signed a written informed consent form
Not Eligible

You will not qualify if you...

  • Unable to read, write, or understand French
  • Considered a vulnerable patient as defined by French Public Health Code Article L1121-6
  • Under guardianship, curatorship, or legal protection ("sauvegarde de justice")
  • Unable to provide informed consent personally according to French Public Health Code Article L1121-8
  • Already participating in another interventional study that could affect outcomes
  • History of urological (prostate) or digestive surgery that may influence study results
  • Refusal to sign the written informed consent form

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinique Sainte Clotilde

Saint-Denis, Reunion, 97404

Actively Recruiting

Loading map...

Research Team

M

MANON Leprince, Clinical Research Associate

CONTACT

M

Mickael Begue, Principal Investigator

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here